Search research articles
Contact Us
Filters
Showing results (231-240 of 352) with videos related to
Page
of 36
Sort By:
Der Anaesthesist
|
May 1, 1986
[Spasticity treatment with spinal morphine or midazolam. In vitro experiments, animal studies and clinical studies on compatibility and effectiveness]
H Müller, H Gerlach, J Boldt, et al.
The Journal of Antimicrobial Chemotherapy
|
November 1, 1982
Ceftizoxime: collaborative multiphased in-vitro evaluation including tentative interpretive standards for disc susceptibility tests, beta-lactamase stability, and inhibition
A L Barry, R N Jones, C Thornsberry, et al.
Gene
|
October 31, 1998
Structural organization of the human TOP2A and TOP2B genes
A J Lang, S E Mirski, H J Cummings, et al.
Journal of Clinical Microbiology
|
January 1, 1989
Quality control limits for the standard anaerobic reference agar dilution susceptibility test procedure of the National Committee for Clinical Laboratory Standards
A L Barry, P C Fuchs, S D Allen, et al.
Antimicrobial Agents and Chemotherapy
|
April 1, 1980
Moxalactam (LY127935), a new semisynthetic 1-oxa-beta-lactam antibiotic with remarkable antimicrobial activity: in vitro comparison with cefamandole and tobramycin
R N Jones, P C Fuchs, H M Sommers, et al.
British Journal of Cancer
|
August 1, 1991
Tumourigenic multidrug-resistant HT1080 cells do not overexpress receptors for epidermal growth factor
M L Slovak, S E Mirski, S P Cole, et al.
Journal of Chemotherapy (Florence, Italy)
|
October 1, 1993
In vitro comparison activity of OPC-17116, a new fluoroquinolone, against more than 5,000 recent clinical isolates from five medical centers
H S Sader, R N Jones, S D Allen, et al.
Diagnostic Microbiology and Infectious Disease
|
September 1, 1992
Cefmetazole and trospectomycin in vitro susceptibility testing interpretive criteria and quality control guidelines for Neisseria gonorrheae
R N Jones, M E Erwin, J A Washington, et al.
Diagnostic Microbiology and Infectious Disease
|
July 1, 1991
Antimicrobial activity of cefpirome. An update compared to five third-generation cephalosporins against nearly 6000 recent clinical isolates from five medical centers
R N Jones, M A Pfaller, S D Allen, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology
|
August 1, 1992
Comparison of fixed concentration and fixed ratio options for testing susceptibility of gram-negative bacilli to piperacillin and piperacillin/tazobactam
M A Pfaller, A L Barry, P C Fuchs, et al.
Page
of 36
Search research articles
Search
Showing results (231-240 of 352) with videos related to
Sort By:
Page
of 36
Der Anaesthesist
|
May 1, 1986
[Spasticity treatment with spinal morphine or midazolam. In vitro experiments, animal studies and clinical studies on compatibility and effectiveness]
H Müller, H Gerlach, J Boldt, et al.
The Journal of Antimicrobial Chemotherapy
|
November 1, 1982
Ceftizoxime: collaborative multiphased in-vitro evaluation including tentative interpretive standards for disc susceptibility tests, beta-lactamase stability, and inhibition
A L Barry, R N Jones, C Thornsberry, et al.
Gene
|
October 31, 1998
Structural organization of the human TOP2A and TOP2B genes
A J Lang, S E Mirski, H J Cummings, et al.
Journal of Clinical Microbiology
|
January 1, 1989
Quality control limits for the standard anaerobic reference agar dilution susceptibility test procedure of the National Committee for Clinical Laboratory Standards
A L Barry, P C Fuchs, S D Allen, et al.
Antimicrobial Agents and Chemotherapy
|
April 1, 1980
Moxalactam (LY127935), a new semisynthetic 1-oxa-beta-lactam antibiotic with remarkable antimicrobial activity: in vitro comparison with cefamandole and tobramycin
R N Jones, P C Fuchs, H M Sommers, et al.
British Journal of Cancer
|
August 1, 1991
Tumourigenic multidrug-resistant HT1080 cells do not overexpress receptors for epidermal growth factor
M L Slovak, S E Mirski, S P Cole, et al.
Journal of Chemotherapy (Florence, Italy)
|
October 1, 1993
In vitro comparison activity of OPC-17116, a new fluoroquinolone, against more than 5,000 recent clinical isolates from five medical centers
H S Sader, R N Jones, S D Allen, et al.
Diagnostic Microbiology and Infectious Disease
|
September 1, 1992
Cefmetazole and trospectomycin in vitro susceptibility testing interpretive criteria and quality control guidelines for Neisseria gonorrheae
R N Jones, M E Erwin, J A Washington, et al.
Diagnostic Microbiology and Infectious Disease
|
July 1, 1991
Antimicrobial activity of cefpirome. An update compared to five third-generation cephalosporins against nearly 6000 recent clinical isolates from five medical centers
R N Jones, M A Pfaller, S D Allen, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology
|
August 1, 1992
Comparison of fixed concentration and fixed ratio options for testing susceptibility of gram-negative bacilli to piperacillin and piperacillin/tazobactam
M A Pfaller, A L Barry, P C Fuchs, et al.
Page
of 36